You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NPM1

Showing 1 - 25 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Acute Lymphoblastic Leukemia, With Appropriate Mutations, Acute Myeloid Leukemia, With NPM1 Mutations Trial (ziftomenib)

Available
  • Acute Lymphoblastic Leukemia, With Appropriate Mutations
  • Acute Myeloid Leukemia, With NPM1 Mutations
  • (no location specified)
Feb 10, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Bologna, Italy
    EMATOLOGIA- AOU Policlinico S.Orsola
Mar 1, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Venetoclax plus Azacitidine
  • standard of care chemotherapy plus gemtuzumab ozogamicin
  • Essen, NRW, Germany
  • +17 more
Jun 6, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

Recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Houston, Texas
  • +5 more
May 31, 2022

CBF and/or NPM1-mutated AML in First Molecular Relapse.

Recruiting
  • Acute Myeloid Leukemia
  • No intervention
  • Angers, France
    Angers University Hospital
Jun 14, 2021

NPMc+ AML Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • NPMc+ AML
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

Acute Myeloid Leukemia Trial in Austria, Germany (Gemtuzumab Ozogamicin (Mylotarg), standard chemo)

Completed
  • Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin (Mylotarg)
  • standard chemotherapy
  • Graz, Austria
  • +59 more
Sep 28, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

Prognosis of AML Patients According to Routinely Used Genetic

Completed
  • Acute Myeloid Leukemia
    • Albacete, Spain
    • +21 more
    Sep 12, 2022

    Immunohistochemical, Histological and Radiological Factors in

    Not yet recruiting
    • Rare Disease With Poor Outcome
      • (no location specified)
      Apr 20, 2022

      Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

      Not yet recruiting
      • Acute Myeloid Leukemia in Children
      • Standard Intervention
      • Investigational Intervention
      • (no location specified)
      Aug 8, 2023

      Relapsed/Refractory Acute Leukemia Trial (SNDX-5613)

      Available
      • Relapsed/Refractory Acute Leukemia
      • (no location specified)
      Jun 15, 2023

      Nucleophosmin 1-mutated Acute Myeloid Leukemia Trial in Worldwide (Entospletinib, Placebo, Cytarabine)

      Recruiting
      • Nucleophosmin 1-mutated Acute Myeloid Leukemia
      • Duarte, California
      • +60 more
      Jul 20, 2022

      Acute Myeloid Leukemia Trial (Sulfasalazine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Oct 11, 2022

      ALL, Adult, AML, Adult Trial (BN104)

      Not yet recruiting
      • ALL, Adult
      • AML, Adult
      • (no location specified)
      Sep 19, 2023

      Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)

      Recruiting
      • Acute Myeloid Leukemia
      • All-trans retinoic acid
      • +2 more
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xi'an Jiaotong University
      Mar 23, 2022

      AML Trial in Netherlands (Flotetuzumab)

      Withdrawn
      • AML
      • Amsterdam, Netherlands
      • +3 more
      Dec 20, 2021

      Type 2 Diabetes Trial (NPM-119 (exenatide implant), Bydureon BCise (exenatide extended release))

      Not yet recruiting
      • Type 2 Diabetes
      • NPM-119 (exenatide implant)
      • Bydureon BCise (exenatide extended release)
      • (no location specified)
      Jan 29, 2023

      Tissue and Blood Samples From Acute Myeloid Leukemia

      Active, not recruiting
      • Leukemia
      • DNA analysis
      • +7 more
      • Mountain View, California
      • +76 more
      Aug 2, 2022

      Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

      Active, not recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +8 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 6, 2022

      Acute Myeloid Leukemia, Adult Trial in Germany (Midostaurin)

      Terminated
      • Acute Myeloid Leukemia, Adult
      • Chemnitz, Germany
      • +3 more
      Jan 20, 2022

      Acute Myeloid Leukemia Trial in Tampa (Vyxeos, Gemtuzumab Ozogamicin)

      Recruiting
      • Acute Myeloid Leukemia
      • Tampa, Florida
        Moffitt Cancer Center
      Sep 23, 2022